Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Charlottesville, VA
NPI: 1033529896Primary Practice Location
UNIVERSITY OF VIRGINIA MEDICAL CENTER
1215 Lee St, Charlottesville, VA
Primary Employer
UVA Physicians Group
virginia.edu
HQ Phone
Get MD Emily's Phone Numberphone_androidMobile
Get MD Emily's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 130 | 185 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 115 | 227 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 70 | 70 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 49 | 184 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 38 | 39 |
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
Authors: Daniel Landsburg, David Margolis
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2020-05-16
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, DRUG: Oral Azacitidine, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: Loxo Oncology, Inc.
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Venetoclax, DRUG: Rituximab, DRUG: Pirtobrutinib